Ethyl 7 Bromo 1 Cyclopropyl 8 Difluoromethoxy 4 Oxo 1 4 Dihydroquinoline 3 Carboxylate
quinoline thiophene imidazole thiazole

Ethyl 7-Bromo-1-Cyclopropyl-8-(Difluoromethoxy)-4-Oxo-1,4-Dihydroquinoline-3-Carboxylate

Taiy Chemical

    Specifications

    HS Code

    943842

    Chemical Name Ethyl 7-Bromo-1-Cyclopropyl-8-(Difluoromethoxy)-4-Oxo-1,4-Dihydroquinoline-3-Carboxylate
    Molecular Formula C17H14BrF2NO4
    Molecular Weight 402.198 g/mol
    Appearance Solid (Typical for this class of compounds, actual may vary)
    Physical State Solid at room temperature
    Solubility Limited solubility in water, likely soluble in organic solvents like dichloromethane, chloroform
    Melting Point Needs experimental determination
    Boiling Point Needs experimental determination
    Density Needs experimental determination
    Pka Related to acidic/basic functional groups, needs experimental determination
    Logp Indicates lipophilicity, needs experimental determination

    As an accredited Ethyl 7-Bromo-1-Cyclopropyl-8-(Difluoromethoxy)-4-Oxo-1,4-Dihydroquinoline-3-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing
    Storage
    Shipping
    Free Quote

    Competitive Ethyl 7-Bromo-1-Cyclopropyl-8-(Difluoromethoxy)-4-Oxo-1,4-Dihydroquinoline-3-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615365036030 or mail to info@alchemist-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365036030

    Email: info@alchemist-chem.com

    General Information
    Where to Buy Ethyl 7-Bromo-1-Cyclopropyl-8-(Difluoromethoxy)-4-Oxo-1,4-Dihydroquinoline-3-Carboxylate in China?
    As a trusted Ethyl 7-Bromo-1-Cyclopropyl-8-(Difluoromethoxy)-4-Oxo-1,4-Dihydroquinoline-3-Carboxylate manufacturer, we deliver: Factory-Direct Value: Competitive pricing with no middleman markups, tailored for bulk orders and project-scale requirements. Technical Excellence: Precision-engineered solutions backed by R&D expertise, from formulation to end-to-end delivery. Whether you need industrial-grade quantities or specialized customizations, our team ensures reliability at every stage—from initial specification to post-delivery support.
    Frequently Asked Questions

    As a leading Ethyl 7-Bromo-1-Cyclopropyl-8-(Difluoromethoxy)-4-Oxo-1,4-Dihydroquinoline-3-Carboxylate supplier, we deliver high-quality products across diverse grades to meet evolving needs, empowering global customers with safe, efficient, and compliant chemical solutions.

    Ethyl 7-Bromo-1-Cyclopropyl-8- (Difluoromethoxy) -4-Oxo-1, what is the chemical structure of 4-Dihydroquinoline-3-Carboxylate
    The Chinese name of this compound is 7-bromo-1-cyclopropyl-8- (difluoromethoxy) -4-oxo-1,4-dihydroquinoline-3-carboxylic acid ethyl ester. Its chemical structure can be resolved from the name as follows:
    - ** Parent nuclear structure **: With quinoline as the basic skeleton, there is an oxo group (= O) at the 4 position of 1,4-dihydroquinoline, which constitutes the basic characteristics of the parent nuclear moiety. Quinoline is a nitrogen-containing heterocyclic compound with a conjugated system. This structure endows the compound with specific chemical activities and physical properties. < Br > - ** Cyclopropyl Substitution **: 1-position connecting cyclopropyl, cyclopropyl is a cyclic structure formed by three carbon atoms. Due to its special ternary ring structure, it has high ring tension, which will affect the spatial structure and reactivity of the whole molecule, so that the molecule exhibits unique properties in some reactions.
    - ** Difluoromethoxy Substitution **: 8-position connecting difluoromethoxy (-OCHF -2), the fluorine atom in this group has a large electronegativity, which will have a significant impact on the electron cloud distribution of the molecule, which in turn affects the polarity and lipophilicity of the molecule. In drug design, such fluorine-containing groups can often change the interaction between drugs and targets.
    - ** Bromine atom substitution **: There are bromine atoms at the 7 position, and the bromine atoms are relatively large. Its introduction will increase the mass and volume of the molecule and affect the intermolecular forces. At the same time, bromine atoms can participate in a variety of chemical reactions as active check points for further structural modification.
    - ** Ester group structure **: The mother nucleus is connected to ethyl carboxylate (-COOCH -2 CH 🥰) at the 3 position. The ester group has certain chemical stability, but under specific conditions, reactions such as hydrolysis can occur. This structure may play an important role in the process of drug metabolism and affect the in vivo process of drugs.
    To sum up, the chemical structure of this compound is composed of the quinoline parent nucleus and multiple different substituents. The mutual influence of each part determines the unique chemical and physical properties of the compound.
    Ethyl 7-Bromo-1-Cyclopropyl-8- (Difluoromethoxy) -4-Oxo-1, what are the main uses of 4-Dihydroquinoline-3-Carboxylate
    Ethyl + 7 - Bromo - 1 - Cyclopropyl - 8- (Difluoromethoxy) - 4 - Oxo - 1,4 - Dihydroquinoline - 3 - Carboxylate, the Chinese name of this compound is roughly 7 - bromo - 1 - cyclopropyl - 8- (difluoromethoxy) - 4 - oxo - 1,4 - dihydroquinoline - 3 - carboxylate ethyl ester. Its main uses are as follows:
    This compound is of great significance in the field of medicine and is often used as a key intermediate in the synthesis of quinolone antibacterial drugs. With their unique chemical structure and mechanism of action, quinolones can effectively inhibit bacterial DNA gyrase or topoisomerase IV, hinder bacterial DNA replication, transcription and repair, and thus exert antibacterial effect. 7-Bromo-1-cyclopropyl-8- (difluoromethoxy) -4-oxo-1,4-dihydroquinoline-3-ethyl carboxylate can introduce specific substituents into the quinolone parent nucleus through a series of reactions to optimize the antibacterial activity, pharmacokinetic properties and safety of the drug. For example, some quinolones derived from this intermediate have good antibacterial activity against Gram-positive and negative bacteria, and are clinically used to treat a variety of infectious diseases such as respiratory tract, urinary tract, and gastrointestinal tract, with definite efficacy.
    In the process of drug development, researchers use 7-bromo-1-cyclopropyl-8- (difluoromethoxy) -4-oxo-1,4-dihydroquinoline-3-carboxylic acid ethyl ester as the basis, and explore the synthesis of new quinolones with broader antibacterial spectrum, stronger activity and higher safety by modifying the structure, providing more options for anti-infection treatment. In addition, in the field of organic synthesis, it can also be used as a building block for the construction of complex organic molecules, expanding the research scope and application scenarios of organic synthetic chemistry.
    Ethyl 7-Bromo-1-Cyclopropyl-8- (Difluoromethoxy) -4-Oxo-1, what is the synthesis method of 4-Dihydroquinoline-3-Carboxylate
    Ethyl 7 - Bromo - 1 - Cyclopropyl - 8 - (Difluoromethoxy) -4 - Oxo - 1,4 - Dihydroquinoline - 3 - Carboxylate, the synthesis method of this compound, let me explain in detail.
    To prepare this compound, the classical route of chemical synthesis is usually followed. The selection of starting materials is quite critical, and the compound with the corresponding functional group is often the starting point. If a quinoline derivative containing a specific substituent is used as the base, the derivative needs to reserve a reactive group at a key position for subsequent introduction of the desired substituent.
    For the introduction of 7-bromine atoms, the electrophilic substitution reaction can be used. With a suitable brominating reagent, such as bromine or N-bromosuccinimide (NBS), under appropriate reaction conditions, such as a suitable solvent (such as halogenated hydrocarbon solvents such as dichloromethane), and a catalytic amount of initiator (such as benzoyl peroxide, etc.), under heating or lighting conditions, the bromine atom is selectively substituted at the 7th position of the quinoline ring.
    1-cyclopropyl access can be achieved by nucleophilic substitution or metal-organic chemistry. The activity check point of cyclopropyl halide (such as cyclopropyl bromide or chlorine) with the corresponding quinoline derivative is reacted in a polar aprotic solvent (such as DMF or DMSO) in the presence of a base (such as potassium carbonate, etc.) to achieve the connection of 1-cyclopropyl group.
    The introduction of 8-difluoromethoxy group, or the preparation of difluoromethoxylation reagent, such as difluoromethanol, is converted into an active intermediate after appropriate treatment, and then reacts with quinoline derivatives. The reaction conditions may need to be precisely regulated, including temperature, reaction time, etc., to ensure that the difluoromethoxy group is selectively connected to the 8 position.
    As for 4-carbonyl and 3-carboxylic acid ethyl ester groups, they are either constructed in the early stage of raw material synthesis, or gradually introduced and modified through subsequent specific reaction steps. If the compound containing ester groups is started, it is converted into a structure containing 4-carbonyl and 3-carboxylic acid ethyl ester groups through a series of reactions.
    During the synthesis process, the purity and yield of each step of the reaction need to be closely monitored. The reaction process is often tracked by thin-layer chromatography (TLC), and the products are purified by column chromatography or recrystallization to ensure the purity of the products obtained in each step. Only then can high-purity Ethyl 7 - Bromo - 1 - Cyclopropyl - 8 - (Difluoromethoxy) -4 - Oxo - 1,4 - Dihydroquinoline - 3 - Carboxylate be obtained.
    Ethyl 7-Bromo-1-Cyclopropyl-8- (Difluoromethoxy) -4-Oxo-1, what are the physical properties of 4-Dihydroquinoline-3-Carboxylate
    Ethyl + 7 - Bromo - 1 - Cyclopropyl - 8 - (Difluoromethoxy) - 4 - Oxo - 1,4 - Dihydroquinoline - 3 - Carboxylate, this is a chemical substance. Its physical properties are crucial and are of great significance in many chemical and industrial applications.
    The appearance of this compound is often a specific form, or crystalline, white or slightly colored, depending on the preparation method and purity. Its melting point and boiling point are also important properties. The melting point is the temperature at which the substance changes from solid to liquid. The melting point of this compound may be within a certain range, which has a great influence on its state transition during heating. The boiling point is related to the temperature at which a substance turns from liquid to gaseous state. Defining the boiling point can help control its volatilization characteristics under different temperature conditions.
    Furthermore, its solubility cannot be ignored. In organic solvents, it either exhibits different solubility properties, or is easily soluble in some organic solvents, such as ethanol, acetone, etc. This property is convenient for its application in chemical reactions and solution preparation. The solubility in water, or poor, is related to the molecular structure and polarity of the compound.
    In addition, density is also one of the physical properties. Density reflects the mass per unit volume of the substance and has a significant impact on its distribution and separation in the mixed system.
    The physical properties of this compound, such as appearance, melting point, boiling point, solubility, and density, are of great value in chemical synthesis, drug discovery, materials science, and many other fields. Researchers can use these properties to better understand and apply the compound.
    What is the market prospect of Ethyl 7-Bromo-1-Cyclopropyl-8- (Difluoromethoxy) -4-Oxo-1, 4-Dihydroquinoline-3-Carboxylate?
    I have heard your inquiry about the market prospect of Ethyl + 7 - Bromo - 1 - Cyclopropyl - 8 - (Difluoromethoxy) -4 - Oxo - 1,4 - Dihydroquinoline - 3 - Carboxylate. This is a specific compound involved in the field of fine chemicals, and its market prospect is complex and subject to many factors.
    First of all, the demand end, the pharmaceutical field may be its key application. If this compound exhibits unique pharmacological activity and advantages in the research and development of antibacterial, anti-inflammatory and other drugs, the demand for it by pharmaceutical companies will surely rise. Today, new types of bacteria are constantly emerging, and there is a hunger for antimicrobial drugs. If this product can meet the market's demand for high-efficiency and low-toxicity antimicrobials, its market potential is limitless. However, pharmaceutical research and development is quite risky. From compound screening to new drug approval, it takes a long time and is expensive, which hinders demand growth.
    Looking at the competitive situation, the chemical industry is highly competitive, with many similar or alternative compounds. If other companies have launched products with similar performance and low cost, or new compounds have emerged in research and development, the market share of this product will be affected. And if companies can build a competitive advantage by means of technical barriers, patent protection, etc., they can also occupy a place in the market.
    At the level of policies and regulations, the chemical and pharmaceutical industries are strictly regulated. Environmental protection policies are becoming stricter, and environmental protection standards for the production process of compounds are improved, and enterprises must invest more costs to meet requirements. Drug approval regulations are also strict, and products need to go through multiple clinical trials and approval processes before they can enter the market. Although such policies ensure the standardized development of the industry, they also increase the difficulty of enterprise operations and marketing activities.
    Technological innovation is also a major factor affecting the market prospects. If new synthetic technologies can reduce production costs and improve product quality, the market competitiveness of this product will be greatly improved. And with the advancement of analysis and detection technology, new discoveries may be made in the performance and application of compounds, expanding their application fields, and then opening up new markets.
    In summary, Ethyl + 7 - Bromo - 1 - Cyclopropyl - 8 - (Difluoromethoxy) -4 - Oxo - 1,4 - Dihydroquinoline - 3 - Carboxylate market prospects present opportunities and challenges. Under the influence of factors such as demand, competition, policies and regulations and technological innovation, enterprises need to evaluate the situation and rely on R & D strength, market strategy and compliance operations to seek development in the market.